PTN · Palatin Technologies Inc
$5.52
-0.47 (-7.85%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 28, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's available cash and cash equivalents as of June 30, 2026, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for one year from the date these consolidated financial statements are issued.”View the 10-K filed Sep 28, 2026
Market Cap
$9.83M
Shares
1.78M
Volume · Oct 20
64.65K
Avg daily vol (3M)
64.72K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.52
Open$5.99
Day$5.40–5.99
52W close$5.52–28.00
Avg vol 30d62K
Short int365K · 20.5% float · 8.0d
Short vol63%
Last earningsSep 28, 2026
DataJan 2020–Oct 2026
Filing10-K · Sep 28
Up next
Next earnings call
Mar 8, 2027
Est · unconfirmed
· in 20 wks
filed Sep 28, 2026
call held Sep 28, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$8.83M
Trailing 12 months
Net income (TTM)
−$8.38M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-98.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$7.49M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+642.5%
Year over year · more shares
Price change (1Y)
-18.0%
Trailing year
Short interest
20.5%
Latest settlement · 8.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−62%
below
Price vs 50-day avg
−44%
below
RSI (14)
22
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−46%
trailing
6-month return
−73%
trailing
YTD return
−64%
this year
Relative strength
−81%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $15 — 200d above 50d
Institutional flow
Flat
2 of 26 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
20.49% of float · ▲ +1.0% MoM · 8.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
26 holders — mid 3-yr range
Squeeze score
66
elevated · 0–100
Fundamentals
EPS growth
+91%
Y/Y
Free cash flow
$-13.6M
Balance sheet
$7.5M
net cash
Quant / Vol
risk profile
Volatility
132%
annualized · 1-yr
Max drawdown
−80%
past year
ATR
18.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Sep 28, 2026
Potential Series J warrant exercise proceeds
· future funding if trigger is hit
$18.5M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−62%
Bearish
Price vs 50-day avg
−44%
Bearish
RSI (14)
22
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $10 › 200d $15 — 200d above 50d
Institutional flow
Flat
2 of 26 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
20.49% of float · ▲ +1.0% MoM · 8.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
26 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $6
Now $6 · 0%
Range high $28
vs 200-day avg -62%
vs 50-day avg -44%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PTN
this stock
Palatin Technologies Inc
|
$9.83M | -64.1% | — | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.07B | +13.5% | +46.2% | 29.9 | 1.8% |
|
MRNA
Moderna, Inc.
|
$96.65B | +720.9% | +4.3% | — | 7.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.13B | +4.6% | +20.8% | 20.0 | 2.1% |
|
CSLLY
Csl Ltd
|
$66.34B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PTN | -32.6% | -46.3% | -72.8% | -37.8% | -64.1% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -31.5% | -45.7% | -80.9% | -38.6% | -76.9% |